Share

November 10, 2015; 85 (19) Clinical/Scientific Notes

Long-term assessment of no evidence of disease activity in relapsing-remitting MS

Nicola De Stefano, Maria Laura Stromillo, Antonio Giorgio, Marco Battaglini, Maria Letizia Bartolozzi, Maria Pia Amato, Maria Pia Sormani
First published October 14, 2015, DOI: https://doi.org/10.1212/WNL.0000000000002105
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
284

Share

Article Information

vol. 85 no. 19 1722-1723
DOI: 
https://doi.org/10.1212/WNL.0000000000002105
PubMed: 
26468405
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received March 4, 2015
  • Accepted in final form July 13, 2015
  • First Published October 14, 2015.

Article Versions

Copyright & Usage: 
© 2015 American Academy of Neurology

Author Disclosures

    1. Nicola De Stefano, MD,
    2. Maria Laura Stromillo, MD,
    3. Antonio Giorgio, MD,
    4. Marco Battaglini, PhD,
    5. Maria Letizia Bartolozzi, MD,
    6. Maria Pia Amato, MD and
    7. Maria Pia Sormani, PhD
  1. Nicola De Stefano, MD,
    2. Scientific Advisory Boards:

    1. Prof. N. De Stefano serves on scientific advisory boards for Merck-Serono, Teva and Novartis Pharma AG

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Travel expense refunds from Biogen Idec, Merck Serono S.A., Bayer-Schering AG, Teva, Sanofi-Aventis and Novartis Pharma AG

    Editorial Boards:

    1. Editorial Advisory Board Member of Neurological Sciences

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Honoraria for lectures from Biogen Idec, Merck Serono S.A., Bayer-Schering AG, Teva, Sanofi-Aventis and Novartis Pharma AG

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Maria Laura Stromillo, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Antonio Giorgio, MD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Marco Battaglini, PhD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Maria Letizia Bartolozzi, MD,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Maria Pia Amato, MD and
    7. Scientific Advisory Boards:

    1. member of Advisory Boards for Biogen-Idec, Merck Serono, Teva, Novartis, Sanofi Aventis, Genzyme and Almirall

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. honoraria for speaking from Biogen-Idec, Merck Serono, Novartis , Teva, Genzyme, Almirall and Sanofi Aventis

    Editorial Boards:

    1. Member of Editorial Board and Associate Editor of BMC Neurology

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. research grants from Biogen Idec, Merk Serono, Bayer Shering, Sanophi Aventis, Teva

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Maria Pia Sormani, PhD
    8. Scientific Advisory Boards:

    1. Commercial entity: BIOGEN IDEC, TEVA

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Merck Serono, TEVA, Genzyme, Novartis, Biogen Idec, Synthon, Roche

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Merck Serono, Biogen, Synthon, TEVA, Genzyme, Roche, Novartis

    Speakers' Bureaus:

    1. Teva, Merck Serono, Biogen, Novartis, Genzyme

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the University of Siena (N.D., M.L.S., A.G., M.B.); the Hospital of Empoli (M.L.B.); the University of Florence (M.P.A.); and the University of Genoa (M.P.S.), Italy.
  1. Correspondence to Prof. Nicola De Stefano: destefano{at}unisi.it
View Full Text

Article usage

Article usage: October 2015 to December 2022

AbstractFullPdfSource
Oct 2015160057Highwire
Nov 20155095366Highwire
Dec 201587913Highwire
Jan 20163975Highwire
Feb 2016421013Highwire
Mar 201628811Highwire
Apr 20162254Highwire
May 20162987Highwire
Jun 20162511Highwire
Jul 20164153Highwire
Aug 20162032Highwire
Sep 20162956Highwire
Oct 20162512Highwire
Nov 20163310Highwire
Dec 20162422Highwire
Jan 20172215Highwire
Feb 20171745Highwire
Mar 20172534Highwire
Apr 20173214Highwire
May 20172445Highwire
Jun 20172213Highwire
Jul 20172101Highwire
Aug 20172124Highwire
Sep 2017712Highwire
Oct 20171633Highwire
Nov 20171900Highwire
Dec 20172610Highwire
Jan 20183633Highwire
Feb 20182122Highwire
Mar 20182395Highwire
Apr 20181822Highwire
May 20181500Highwire
Jun 20182923Highwire
Jul 20182612Highwire
Aug 20181700Highwire
Sep 20182311Highwire
Oct 20181901Highwire
Nov 20181600Highwire
Dec 20181300Highwire
Jan 20191923Highwire
Feb 20193211Highwire
Mar 20191600Highwire
Apr 20193423Highwire
May 20192913Highwire
Jun 20192132Highwire
Jul 20191400Highwire
Aug 20192800Highwire
Sep 20191200Highwire
Oct 20191100Highwire
Nov 20191601Highwire
Dec 20192100Highwire
Jan 20201800Highwire
Feb 20201202Highwire
Mar 20201300Highwire
Apr 20201011Highwire
May 2020911Highwire
Jun 2020311Highwire
Jul 2020800Highwire
Aug 2020600Highwire
Sep 20201300Highwire
Oct 20201324Highwire
Nov 20202412Highwire
Dec 2020601Highwire
Jan 20211422Highwire
Feb 20211500Highwire
Mar 20212011Highwire
Apr 20211300Highwire
May 20211200Highwire
Jun 2021700Highwire
Jul 20214411Highwire
Aug 20212100Highwire
Sep 20212810Highwire
Oct 20213101Highwire
Nov 20213500Highwire
Dec 20213101Highwire
Jan 20221211Highwire
Feb 20222400Highwire
Mar 20221000Highwire
Apr 20222210Highwire
May 20221900Highwire
Jun 20221800Highwire
Jul 20222001Highwire
Aug 20222303Highwire
Sep 20221101Highwire
Oct 20222100Highwire
Nov 20223000Highwire
Dec 20221200Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me